BTIG analyst Mark Massaro downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.
‘Yahoo eyes retail stock trading in major growth push’ – Axios
https://www.axios.com/2022/11/29/yahoo-eyes-stock-trading-amid-growth-push
BTIG Downgrades T2 Biosystems to Neutral
BTIG analyst Mark Massaro downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.
Related Posts
Regulation Rumble: Unpacking The Coinbase-SEC Showdown And What It Means For Crypto
The Securities and Exchange Commission’s (SEC) Wells notice to Coinbase (NASDAQ: COIN) has sent ripples across the cryptocurrency industry, with experts expressing concerns over the regulator's approach to regulating the market.
Unveiling 8 Analyst Insights On Northern Oil & Gas
Across the recent three months, 8 analysts have shared their insights on Northern Oil & Gas (NYSE:NOG), expressing…
Piper Sandler Maintains Overweight on Delek US Hldgs, Lowers Price Target to $46
Piper Sandler analyst Ryan Todd maintains Delek US Hldgs (NYSE:DK) with a Overweight and lowers the price target from $47 to $46.